Filgrastim for Premature Ovarian Insufficiency (FIL-POI)
Filgrastim for Treatment of Premature Ovarian Insufficiency: Randomized Clinical Trial
Sponsor: South Valley University
This PHASE4 trial investigates Premature Ovarian Failure and is currently completed. South Valley University leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE4
-
Dec 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- South Valley University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.